COO · NMS · Healthcare
The Cooper Companies, Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 38.93
Market price
USD 61.30
Implied upside
-36.5%
10-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case · Price 2026-11-02 · Accounts to 2025-10-31
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 | FY33 | FY34 | FY35 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD 4.2bn | USD 4.4bn | USD 4.6bn | USD 4.7bn | USD 4.9bn | USD 5.1bn | USD 5.2bn | USD 5.4bn | USD 5.5bn | USD 5.7bn | +3.3% |
| EBIT | USD 688.6m | USD 716.3m | USD 743.7m | USD 770.7m | USD 797.3m | USD 823.3m | USD 848.5m | USD 873.0m | USD 896.4m | USD 918.9m | +3.3% |
| NOPAT | USD 544.0m | USD 565.8m | USD 587.5m | USD 608.9m | USD 629.9m | USD 650.4m | USD 670.3m | USD 689.6m | USD 708.2m | USD 725.9m | +3.3% |
| Add depreciation & amortisation | USD 419.1m | USD 435.9m | USD 452.6m | USD 469.0m | USD 485.2m | USD 501.0m | USD 516.4m | USD 531.3m | USD 545.5m | USD 559.2m | +3.3% |
| Less capital expenditure | USD -401.7m | USD -420.9m | USD -440.3m | USD -459.7m | USD -479.0m | USD -498.2m | USD -517.2m | USD -535.9m | USD -554.2m | USD -572.1m | +4.0% |
| Capex, % of revenue | 9.5% | 9.5% | 9.6% | 9.7% | 9.8% | 9.8% | 9.9% | 10.0% | 10.0% | 10.1% | - |
| Less increase in working capital | USD -45.7m | USD -53.2m | USD -52.7m | USD -52.0m | USD -51.1m | USD -50.0m | USD -48.6m | USD -47.0m | USD -45.1m | USD -43.1m | -0.7% |
| Free cashflow to firm | USD 515.7m | USD 527.6m | USD 547.1m | USD 566.2m | USD 585.0m | USD 603.2m | USD 621.0m | USD 638.0m | USD 654.4m | USD 669.9m | +3.0% |
| Discount factor | 0.9629 | 0.8929 | 0.8279 | 0.7677 | 0.7118 | 0.6600 | 0.6120 | 0.5675 | 0.5262 | 0.4879 | - |
| Present value | USD 496.5m | USD 471.1m | USD 452.9m | USD 434.7m | USD 416.4m | USD 398.2m | USD 380.0m | USD 362.1m | USD 344.3m | USD 326.9m | - |
| Present Value Of The Forecast | USD 4.1bn | ||||||||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 4.89% | US 10-year Treasury (^TNX), 2026-11-02 |
| Equity risk premium | 4.23% | Damodaran, January 2026 |
| Beta | 0.878 | Reported 0.818, pulled toward 1.0 (Blume) |
| Cost of equity | 8.61% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.44% | Risk-free + 55bp, the spread for a AA rating at 6.8x interest cover. Book interest / average debt was lower, at 3.9%. |
| Market capitalisation | USD 11.7bn | 82.3% of capital |
| Total debt | USD 2.5bn | 17.7% of capital, book value as a proxy |
| Tax rate | 21.0% | Effective, capped at statutory |
| WACC | 7.85% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
60% of EV
- Forecast FCFF, final year
- USD 669.9m
- Capex at depreciation, working capital in reinvestment
- USD 956.5m
- Less reinvestment at g/ROIC (31.9% of NOPAT)
- USD -304.8m
- Capitalised
- USD 651.7m
- ROIC (WACC floor)
- 7.8%
- Terminal value, undiscounted
- USD 12.5bn
- Terminal value, discounted
- USD 6.1bn
- Enterprise value
- USD 10.2bn
- Less net debt
- USD 2.4bn
- Equity value
- USD 7.8bn
Exit at 13.3x EBITDA
70% of EV
- Terminal value, undiscounted
- USD 19.6bn
- Terminal value, discounted
- USD 9.6bn
- Enterprise value
- USD 13.6bn
- Less net debt
- USD 2.4bn
- Equity value
- USD 11.2bn
Spread between methods: 36%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 5.85% | 59.65 | 58.60 | 57.55 | 56.50 | 55.45 |
| 6.85% | 48.55 | 47.71 | 46.86 | 46.01 | 45.16 |
| 7.85% | 40.32 | 39.62 | 38.92 | 38.23 | 37.53 |
| 8.85% | 33.99 | 33.40 | 32.81 | 32.23 | 31.64 |
| 9.85% | 28.97 | 28.47 | 27.97 | 27.47 | 26.97 |
Outlined: this model. Green text: above today's price of 61.30. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Actual | Model | Implied | Gap |
|---|---|---|---|---|
| Revenue growth, a year | 7.3% | 3.3% | 8.1% | |
| EBIT margin | 18.1% | 16.2% | 24.9% | |
| Discount rate | - | 7.8% | 5.6% |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.